Latest news

CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent. This is a 110 percent decrease over losses of $(0.10) per share from the

CytoSorbents (NASDAQ:CTSO) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:15 PM. Here's what investors need to know about the announcement. Earnings CytoSorbents missed estimated earnings by 75.0%, reporting an EPS of $-0.21 versus an estimate of $-0.12.

  Companies Reporting Before The Bell • Kiniksa Pharmaceuticals (NASDAQ:KNSA) is projected to report earnings for its first quarter.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  During Tuesday, 581 stocks hit new 52-week lows. Interesting Highlights From Today's 52-Week Lows Meta Platforms (NASDAQ:FB) was the biggest company on a market cap basis to set a new 52-week low.

  On Friday =, 431 companies hit new 52-week lows.

  On Tuesday, 242 companies hit new 52-week lows.

  During Tuesday's session, 454 stocks hit new 52-week lows.

Gainers